Show simple item record

dc.contributor.authorHanson, MA
dc.date.accessioned2024-07-22T12:23:08Z
dc.date.issued2024-03-18
dc.date.updated2024-07-18T21:24:57Z
dc.description.abstractThe microbiome includes both 'mutualist' and 'pathogen' microbes, regulated by the same innate immune architecture. A major question has therefore been: how do hosts prevent pathogenic infections while maintaining beneficial microbes? One idea suggests hosts can selectively activate innate immunity upon pathogenic infection, but not mutualist colonization. Another idea posits that hosts can selectively attack pathogens, but not mutualists. Here I review evolutionary principles of microbe recognition and immune activation, and reflect on newly observed immune effector-microbe specificity perhaps supporting the latter idea. Recent work in Drosophila has found a surprising importance for single antimicrobial peptides in combatting specific ecologically relevant microbes. The developing picture suggests these effectors have evolved for this purpose. Other defence responses like reactive oxygen species bursts can also be uniquely effective against specific microbes. Signals in other model systems including nematodes, Hydra, oysters, and mammals, suggest that effector-microbe specificity may be a fundamental principle of host-pathogen interactions. I propose this effector-microbe specificity stems from weaknesses of the microbes themselves: if microbes have intrinsic weaknesses, hosts can evolve effectors that exploit those weaknesses. I define this host-microbe relationship as 'the Achilles principle of immune evolution'. Incorporating this view helps interpret why some host-microbe interactions develop in a coevolutionary framework (e.g. Red Queen dynamics), or as a one-sided evolutionary response. This clarification should be valuable to better understand the principles behind host susceptibilities to infectious diseases. This article is part of the theme issue 'Sculpting the microbiome: how host factors determine and respond to microbial colonization'.en_GB
dc.description.sponsorshipSwiss National Science Foundationen_GB
dc.identifier.citationVol. 379(1901), article 20230061en_GB
dc.identifier.doihttps://doi.org/10.1098/rstb.2023.0061
dc.identifier.grantnumberP500PB_211082en_GB
dc.identifier.urihttp://hdl.handle.net/10871/136812
dc.identifierORCID: 0000-0002-6125-3672 (Hanson, Mark A)
dc.language.isoenen_GB
dc.publisherThe Royal Societyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/38497259en_GB
dc.rights© 2024 The Authors. Open access. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.en_GB
dc.subjectantimicrobial peptideen_GB
dc.subjecthost defence peptideen_GB
dc.subjecthost–microbe interactionsen_GB
dc.subjecthost–pathogenen_GB
dc.subjectmicrobiotaen_GB
dc.subjectreactive oxygen speciesen_GB
dc.titleWhen the microbiome shapes the host: immune evolution implications for infectious diseaseen_GB
dc.typeArticleen_GB
dc.date.available2024-07-22T12:23:08Z
dc.identifier.issn0962-8436
exeter.article-number20230061
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available on open access from the Royal Society via the DOI in this recorden_GB
dc.descriptionData accessibility: This article has no additional data.en_GB
dc.identifier.eissn1471-2970
dc.identifier.journalPhilosophical Transactions of the Royal Society B: Biological Sciencesen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-08-08
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2024-03-18
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-22T12:20:39Z
refterms.versionFCDVoR
refterms.dateFOA2024-07-22T12:23:27Z
refterms.panelAen_GB
refterms.dateFirstOnline2024-03-18


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2024 The Authors. Open access. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
Except where otherwise noted, this item's licence is described as © 2024 The Authors. Open access. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.